Blog _Blog Implementation of ICH Q12 in Europe: where are we now? Read more » March 5, 2026 _Blog Centralised Procedure Read more » February 13, 2026 _Blog Do “over the counter” medicines exist in France? Read more » February 13, 2026 _Blog Clinical Trials versus Research Involving Human Subjects (RIPH): How Are Pharmaceutical Companies Affected? Read more » February 3, 2026 _Blog Understanding EUDAMED: The European Database on Medical Devices Read more » January 28, 2026 _Blog New ICH M4Q(R2) guidelines: towards a paradigm shift for Module 2.3 and 3 formats Read more » January 16, 2026 _Blog The Post-Approval Change Management Protocol or “PACMP” Read more » January 6, 2026 _Blog How to manage a non-GMP raw material in your MA files? Read more » December 23, 2025 _Blog Conditions for the Prescription and Dispensing of Medicines in France Read more » December 4, 2025 _Blog The Hospital-to-Community Dispensing (“Retrocession”) of Hospital Medicines to Outpatients in France Read more » December 1, 2025 _Blog The PRRC: Person Responsible for Regulatory Compliance Read more » December 1, 2025 _Blog Marketing Autorisation Extension versus type II variation. Read more » November 12, 2025 Page1 Page2 Page3 Page4
_Blog Clinical Trials versus Research Involving Human Subjects (RIPH): How Are Pharmaceutical Companies Affected? Read more » February 3, 2026
_Blog New ICH M4Q(R2) guidelines: towards a paradigm shift for Module 2.3 and 3 formats Read more » January 16, 2026
_Blog Conditions for the Prescription and Dispensing of Medicines in France Read more » December 4, 2025
_Blog The Hospital-to-Community Dispensing (“Retrocession”) of Hospital Medicines to Outpatients in France Read more » December 1, 2025
